From R&D to GMP: Key Considerations for Cell and Gene Therapy Manufacturing

Download the Interactive guide to learn more.

Developing and scaling cell and gene therapies introduces complex operational and manufacturing challenges—from reducing contamination risk and maintaining reproducibility to meeting evolving GMP requirements and scaling processes without compromising quality.

This interactive guide explores five critical considerations for building more robust cell and gene therapy workflows: contamination control, compliance, reproducibility, monitoring and scalability.

Download to explore key considerations for:

Reducing contamination risk as processes become more complex
Supporting reproducibility and consistency across workflows
Preparing laboratory processes and environments for GMP requirements
Strengthening monitoring and control as operations scale
Evaluating equipment considerations across CO₂ incubation, centrifugation, biological safety and cold storage

Gain practical guidance to help inform workflow and equipment decisions as cell and gene therapy programs progress from R&D toward GMP manufacturing. Access this valuable resource today!

FILL THE FORM BELOW

First Name *

Last Name *

Company Street Address *

Company Suite/Office *

Company Postal/Zip Code *

Company City *

Company State *

Company Country *

By submitting this content request, I have legitimate interest in the content and agree that Thermo Fisher Scientific, their partners, and the creators of any other content I have selected may contact me regarding news, products, and services that may be of interest to me.

YesNo